Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment
CompletedOBSERVATIONAL
Enrollment
201
Participants
Timeline
Start Date
November 20, 2018
Primary Completion Date
July 6, 2023
Study Completion Date
July 6, 2023
Conditions
Non Hodgkin LymphomaNon Small Cell Lung CancerGlioma
Trial Locations (1)
75013
Groupe Hospitalier Pitié-Salpêtrière, Paris
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
NCT03706625 - Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment | Biotech Hunter | Biotech Hunter